Metacrine, Inc.
MTCRDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001634379
Metacrine, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Mar 24, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $7.29M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Metacrine, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 25 | 27 | +2 |
| Shares | 6.12M | 8.11M | +1.98M (+32.4%) |
| Value | $3.06M | $3.93M | +$870.0K (+28.4%) |
New holders (6)
Institutions that held Metacrine, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 1,718,220 | $833.0K | 0.10% |
| Tudor Investment Corp Et Al | 349,100 | $169.0K | 0.00% |
| Jane Street Group, LLC | 173,328 | $84.0K | 0.00% |
| CSS LLC | 169,344 | $82.0K | 0.00% |
| Citadel Advisors LLC | 136,606 | $66.0K | 0.00% |
| JPMorgan Chase & Co | 3 | $0 | 0.00% |
Sold out (4)
Institutions that held Metacrine, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Pura Vida Investments, LLC | 198,230 | $99.0K |
| Crestline Management, LP | 158,659 | $79.0K |
| Virtu Financial LLC | 28,468 | $14.0K |
| Credit Suisse AG | 244 | $0 |